Arcutis Biotherapeutics, Inc.

ARQT · NASDAQ
Analyze with AI
$28.34−$0.19 (−0.67%)
At close:Dec 17, 2025, 9:00 PM UTC
$28.30−$0.0401 (−0.14%)
After hours:Dec 18, 2025, 12:57 AM UTC
P/E TTM-81.6
P/B TTM22.88
P/S TTM10.92
Dividend Yield0%
EPS-$0.34
Beta1.703
Valuation
PEG Ratio-1.57
FCF Yield-1.10%
EV / EBITDA-143.21
Quality
ROIC-14.38%
Gross Margin89.96%
Cash Conv. Ratio0.73
Growth
Revenue 3Y CAGR276.39%
FCF Growth54.62%
Safety
Net Debt / EBITDA1.71
Interest Coverage-2.61
Efficiency
Inventory Turnover1.42
Cash Conv. Cycle322.30

Arcutis Biotherapeutics, Inc. (ARQT) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Arcutis Biotherapeutics, Inc. (ARQT) stock price today?

As of Dec 17, 2025, 9:00 PM UTC, Arcutis Biotherapeutics, Inc. (ARQT) stock is trading at $28.34. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date ARQT stock quotes for informed trading decisions.

What is Arcutis Biotherapeutics, Inc.'s market capitalization?

Arcutis Biotherapeutics, Inc. (ARQT) has a market capitalization of approximately $3.5B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Arcutis Biotherapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the ARQT stock price changes.

What is the 52-week range for Arcutis Biotherapeutics, Inc. stock?

Arcutis Biotherapeutics, Inc. (ARQT) stock has traded in a 52-week range of $11.13 — $31.77. The 52-week range shows the highest and lowest prices at which ARQT traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Arcutis Biotherapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Arcutis Biotherapeutics, Inc. stock have?

Arcutis Biotherapeutics, Inc. (ARQT) stock recently traded approximately 1.3M shares. Trading volume indicates market liquidity and investor interest in ARQT. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Arcutis Biotherapeutics, Inc. stock.

Does Arcutis Biotherapeutics, Inc. pay dividends to shareholders?

Yes, Arcutis Biotherapeutics, Inc. (ARQT) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Arcutis Biotherapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Arcutis Biotherapeutics, Inc.'s intraday price range?

Today, Arcutis Biotherapeutics, Inc. (ARQT) stock has traded in a range of $28.05 — $28.69. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring ARQT's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Arcutis Biotherapeutics, Inc. stock data?

AlphaPilot sources real-time ARQT stock quotes, fundamental financial data, and historical price charts for Arcutis Biotherapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Arcutis Biotherapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of ARQT stock performance.